Krishnan, Biju <br/><br/>
Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study.  [electronic resource] 

 -  British journal of haematology  Jun 2010 
 - 907-10 p.  digital 
<br/><br/> Publication Type: Letter; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2010.08134.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alemtuzumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Combined Modality Therapy<br/>Female<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Leukemia, Prolymphocytic, T-Cell--therapy<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome